Get a Quote

AMISULPRIDE
CAS NO.: 71675-85-9
Chemical Formula: C17H27N3O4S
Molecular Weight: 369.5000
DMF&GMP status: Please contact us for more details.
Description:
Amisulpride is a member of the class of benzamides resulting from the formal condensation of the carboxy group of 4-amino-5-(ethylsulfonyl)-2-methoxybenzoic acid with the primary amino group of 2-(aminomethyl)-1-ethylpyrrolidine. It is a potent, selective dopamine D2 and D3 receptor antagonist. It is an atypical antipsychotic/antischizophrenic agent with limited extrapyrimidal side effects. It has a role as a second generation antipsychotic, a xenobiotic and an environmental contaminant. It is a member of pyrrolidines, an aromatic amine, a sulfone, a member of benzamides and an aromatic amide.

Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.

**The products protected by patents in this product catalog are used for laboratory analysis, research and development, and cannot be sold to any country or region with patent protection and for commercial purpose. If the resulting patent infringement risks and responsibilities will be borne by the buyer.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
AMISULPRIDESOLUTION;INTRAVENOUS5MG/2ML (2.5MG/ML)BARHEMSYSACACIA PHARMA LTD
AMISULPRIDESOLUTION;INTRAVENOUS10MG/4ML (2.5MG/ML)BARHEMSYSACACIA PHARMA LTD
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
908476503/10/2031U-1744 U-2754
954542603/10/2031U-1744 U-2754
988911803/10/2031U-1744 U-2754
1052503303/10/2031DP
Exclusive Data
Exclusivity Code Exclusivity Expiration
NCE 02/26/2025